Freeline Therapeutics Holdings plc - stock earnings

FRLN Quarterly earnings

DateEarningsRevenue
2023Q3 -12.1 million USD 5000 USD
2023Q2 -16.0 million USD 617000 USD
2023Q1 -23.0 million USD ? USD
2022Q4 -23.0 million USD ? USD
2022Q3 -14.9 million USD ? USD
2022Q2 -24.3 million USD ? USD
2022Q1 -26.7 million USD ? USD
2021Q4 -34.7 million USD ? USD
2021Q3 -30.9 million USD ? USD
2021Q2 -39.9 million USD ? USD
2021Q1 -34.9 million USD ? USD
2020Q4 -38.1 million USD ? USD
2020Q3 -25.0 million USD ? USD
2020Q2 -16.6 million USD ? USD
2020Q1 -16.7 million USD ? USD
2019Q2 -13.5 million USD ? USD
2019Q1 -13.5 million USD ? USD
2018Q4 -13.5 million USD ? USD
2018Q2 -8.3 million USD ? USD
2018Q1 -8.3 million USD ? USD
2017Q4 -8.3 million USD ? USD

FRLN Yearly earnings

DateEarningsRevenue
2023 -49.9 million USD 622000 USD
2022 -89.0 million USD 617000 USD
2021 -140.4 million USD ? USD
2020 -96.3 million USD ? USD
2019 -53.9 million USD ? USD
2018 -33.3 million USD ? USD
2017 -12.5 million USD ? USD

FRLN

Price: $6.49

52 week price:
2.11
9.17

Earnings Per Share: -11.45 USD

P/E Ratio: -0.56

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 189900

Market Capitalization: 28.2 million

Links: